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Background
Population over 65 years old represents the fastest grow-
ing group of overall population. Considering that almost
70% of pancreatic cancer patients are over 65 years old,
therefore an increasing number of elderly patients should
be considered for pancreatic resective surgery. The aim of
our study is to compare the outcome after pancreatic
resective surgery for cancer between young (under 70
years) and old (over 70 years) patients.
Materials and methods
We reviewed the clinical records of all the patients that
underwent radical surgery for pancreatic ductal adenocar-
cinoma in the period from January 2001 to December
2007 in our department. We collected 66 patients, divided
into two groups according to age under 70 (group A) or
over 70 years old (group B). For both group we analyzed
tumour stage, ASA score, hospital stay length, postopera-
tive morbidities and mortality, overall survival.
Results
Group A is composed by 38 patients (21 male, 17 female,
mean age 56.1 ± 8.7 years) and group B by 28 patients (14
males, 14 female, mean age 76.9 ± 3.5 years). The two
groups are comparable in terms of surgical procedure and
tumor stage; group B patients show a higher ASA score
level (p = 0.001 vs Group A). There is no significant differ-
ence between Group A and B in mortality rate (2.6% vs
3.6%), postoperative morbidity (60.5% vs 57.2%), hospi-
tal stay length (20.8 ± 13.9 vs 18.5 ± 9.1 days) and median
overall survival (27.7 vs 15, 9 months, p = 0.08).
Conclusion
This study shows that there is no significant difference in
morbidity, mortality and hospital stay length between
young patients and old patients, after pancreatic resective
surgery for cancer. Although ASA score is higher in old
patients, this factor seems not to affect the short-term out-
come of these patients. The median overall survival of old
patients leans towards being less than young patients
(15.9 vs 27.7 months), however, without significant sta-
tistical difference. Probably this shortened survival can be
explained by a less aggressive chemo-radiotherapy adju-
vant treatment that old patients receive. In conclusion,
according to literature, age should not be considered a
contraindication to pancreatic resection surgery for can-
cer. Furthermore to elderly patients should be offered the
same surgical and adjuvant treatment options as to young
patients, taking into consideration preoperative comor-
bidities.
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